164 related articles for article (PubMed ID: 17513019)
1. Quantitative structure activity relationship studies on thiourea analogues as influenza virus neuraminidase inhibitors.
Nair PC; Sobhia ME
Eur J Med Chem; 2008 Feb; 43(2):293-9. PubMed ID: 17513019
[TBL] [Abstract][Full Text] [Related]
2. Molecular docking and QSAR studies on substituted acyl(thio)urea and thiadiazolo [2,3-alpha] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
Sun J; Cai S; Mei H; Li J; Yan N; Wang Q; Lin Z; Huo D
Chem Biol Drug Des; 2010 Sep; 76(3):245-54. PubMed ID: 20626407
[TBL] [Abstract][Full Text] [Related]
3. Quantitative structure activity relationship studies of aryl heterocycle-based thrombin inhibitors.
Deswal S; Roy N
Eur J Med Chem; 2006 Nov; 41(11):1339-46. PubMed ID: 16884829
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of a new series of substituted acyl(thio)urea and thiadiazolo [2,3-a] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
Sun C; Zhang X; Huang H; Zhou P
Bioorg Med Chem; 2006 Dec; 14(24):8574-81. PubMed ID: 16979342
[TBL] [Abstract][Full Text] [Related]
5. QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors.
Mercader AG; Pomilio AB
Eur J Med Chem; 2010 May; 45(5):1724-30. PubMed ID: 20116898
[TBL] [Abstract][Full Text] [Related]
6. Pharmacophore modeling, quantitative structure-activity relationship analysis, and shape-complemented in silico screening allow access to novel influenza neuraminidase inhibitors.
Abu Hammad AM; Taha MO
J Chem Inf Model; 2009 Apr; 49(4):978-96. PubMed ID: 19341295
[TBL] [Abstract][Full Text] [Related]
7. On three-dimensional holographic vector of atomic interaction field analysis for influenza neuraminidase inhibitors.
Li ZS; Sun JY; Liang GZ; Lu FL; Zhu WP; Zhang MJ; Zhang Y; Yang SB; Shu M; Chen GH; Lu TT
Chem Biol Drug Des; 2009 Feb; 73(2):236-43. PubMed ID: 19207426
[TBL] [Abstract][Full Text] [Related]
8. Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors.
Nargotra A; Sharma S; Koul JL; Sangwan PL; Khan IA; Kumar A; Taneja SC; Koul S
Eur J Med Chem; 2009 Oct; 44(10):4128-35. PubMed ID: 19523722
[TBL] [Abstract][Full Text] [Related]
9. Quantitative structure-activity relationship (QSAR) of aryl alkenyl amides/imines for bacterial efflux pump inhibitors.
Nargotra A; Koul S; Sharma S; Khan IA; Kumar A; Thota N; Koul JL; Taneja SC; Qazi GN
Eur J Med Chem; 2009 Jan; 44(1):229-38. PubMed ID: 18395941
[TBL] [Abstract][Full Text] [Related]
10. QSAR study of neuraminidase inhibitors based on heuristic method and radial basis function network.
Lü WJ; Chen YL; Ma WP; Zhang XY; Luan F; Liu MC; Chen XG; Hu ZD
Eur J Med Chem; 2008 Mar; 43(3):569-76. PubMed ID: 18255197
[TBL] [Abstract][Full Text] [Related]
11. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
12. Influenza virus neuraminidase inhibitors: generation and comparison of structure-based and common feature pharmacophore hypotheses and their application in virtual screening.
Steindl T; Langer T
J Chem Inf Comput Sci; 2004; 44(5):1849-56. PubMed ID: 15446845
[TBL] [Abstract][Full Text] [Related]
13. Neuraminidase pharmacophore model derived from diverse classes of inhibitors.
Zhang J; Yu K; Zhu W; Jiang H
Bioorg Med Chem Lett; 2006 Jun; 16(11):3009-14. PubMed ID: 16530411
[TBL] [Abstract][Full Text] [Related]
14. Docking and 3D-QSAR studies of influenza neuraminidase inhibitors using three-dimensional holographic vector of atomic interaction field analysis.
Sun J; Cai S; Yan N; Mei H
Eur J Med Chem; 2010 Mar; 45(3):1008-14. PubMed ID: 19969399
[TBL] [Abstract][Full Text] [Related]
15. Docking and 3D QSAR study of thiourea analogs as potent inhibitors of influenza virus neuraminidase.
Sun J; Cai S; Mei H; Li J; Yan N; Wang Y
J Mol Model; 2010 Dec; 16(12):1809-18. PubMed ID: 20213331
[TBL] [Abstract][Full Text] [Related]
16. Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
Rungrotmongkol T; Frecer V; De-Eknamkul W; Hannongbua S; Miertus S
Antiviral Res; 2009 Apr; 82(1):51-8. PubMed ID: 19428595
[TBL] [Abstract][Full Text] [Related]
17. Characteristic of alkylated chalcones from Angelica keiskei on influenza virus neuraminidase inhibition.
Park JY; Jeong HJ; Kim YM; Park SJ; Rho MC; Park KH; Ryu YB; Lee WS
Bioorg Med Chem Lett; 2011 Sep; 21(18):5602-4. PubMed ID: 21824777
[TBL] [Abstract][Full Text] [Related]
18. Novel linear polymers bearing thiosialosides as pendant-type epitopes for influenza neuraminidase inhibitors.
Matsuoka K; Takita C; Koyama T; Miyamoto D; Yingsakmongkon S; Hidari KI; Jampangern W; Suzuki T; Suzuki Y; Hatano K; Terunuma D
Bioorg Med Chem Lett; 2007 Jul; 17(14):3826-30. PubMed ID: 17524642
[TBL] [Abstract][Full Text] [Related]
19. Pharmacophore model of influenza neuraminidase inhibitors--a systematic review.
Gong JZ; Liu Y; Xu WF
Pharmazie; 2009 Oct; 64(10):627-32. PubMed ID: 19947162
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core.
Wang GT; Wang S; Gentles R; Sowin T; Maring CJ; Kempf DJ; Kati WM; Stoll V; Stewart KD; Laver G
Bioorg Med Chem Lett; 2005 Jan; 15(1):125-8. PubMed ID: 15582424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
